Dla zespołu autorów

I miejsce

Parczewski M, Cielniak I, Kordek J, Aksak-Wąs B, Urbańska A, Leszczyszyn-Pynka M, Siwak E, Bociąga-Jasik M, Nowak A, Szymczak A, Zalewska M, Łojewski W, Vandamme AM, Lübke N, Cuypers L.

Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland.

J Acquir Immune Defic Syndr  2018;77(5):514-522

IF 4,116

II miejsce

Kowalska JD, Bursa D, Gökengin D, Jilich D, Tomazic J, Vasylyev M, Bukovinowa P, Mulabdic V, Antonyak S, Horban A; ECEE Network Group.

HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.

HIV Med. 2018 Oct;19(9):629-633

IF 2,932

III miejsce

Kowalska JD, Ankiersztejn-Bartczak M, Shepherd L, Mocroft A.

Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project.

Infection. 2018 Aug;46(4):533-540. doi: 10.1007/s15010-018-1154-0. Epub 2018 May 21.

IF 2,773

CYKL PRAC dla:

Elżbieta Jabłonowska:

1: Jabłonowska E, Siwak E, Bociąga-Jasik M, Gąsiorowski J, Kalinowska A, Firląg Burkacka E, Wójcik-Cichy K, Piątek A, Cielniak I, Horban A.

Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in

HIV-1-infected treatment-experienced patients.

PLoS One. 2019 Jan 17;14(1):e0210476. doi: 10.1371/journal.pone.0210476. eCollection 2019. PubMed

IF 2,766

2: Jabłonowska E, Pulik P, Kalinowska A, Gąsiorowski J, Parczewski M, Bociąga-Jasik M, Mularska E, Pulik Ł, Siwak E, Wójcik K.

Dual therapy based on raltegravir and boosted protease inhibitors - the experience of Polish centers.

Arch Med Sci. 2018 Jun;14(4):860-864.

IF 2,344

3: Jabłonowska E, Pulik P, Kalinowska A, Gąsiorowski J, Parczewski M, Bociąga-Jasik M, Pulik Ł, Siwak E, Wójcik K.

Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.

J Med Virol. 2017 Dec;89(12):2122-2129. doi: 10.1002/jmv.24826. Epub 2017 Aug 31. PubMed PMID:

28390164.

IF 1.988

Łącznie 7,092